Table 1.
AD | PD/DLB | FTLD | PSP/CBD | MND | ND | |
---|---|---|---|---|---|---|
Patients (n) | 48 | 43 | 36 | 12 | 21 | 34 |
Age range (years) | 50–92 | 54–89 | 31–80 | 64–91 | 45–72 | 26–94 |
Mean age ± SD (years) | 71.7 ± 10.2 | 76.9 ± 7.7 | 63.9 ± 11.1 | 76.9 ± 10.6 | 61.7 ± 11.7 | 72.0 ± 20.1 |
Mean age at onset ± SD (years) | 61.5 ± 11.4 | 63.9 ± 11.0 | 55.9 ± 11.6 | 69.3 ± 10.2 | 62.5 ± 3.5 | – |
Mean disease duration ± SD (years) | 9.0 ± 3.5 | 13.2 ± 7.9 | 7.7 ± 4.5 | 7.7 ± 4.2 | 3.5 ± 2.1 | – |
Gender: male:female N (%) | 17:26 (39.5:56.5) | 32:9 (74.4:21.0) | 21:12 (58.3:33.3) | 10:2 (83:17) | 13:7 (62:33) | 11:21 (32.4:61.8) |
AD Alzheimer’s disease, PD/DLB Parkinson’s disease/dementia with Lewy bodies, FTLD frontotemporal lobar degeneration, PSP/CBD progressive supranuclear palsy/corticobasal degeneration, MND motor neuron disease, ND non-demented